17th Urological Association of Asia Congress (UAA) 2019

07 August 2019 - 10 August 2019

Immunotherapy promising treatment option for metastatic castrate-resistant prostate cancer

Pank Jit Sin, 20190903014220

Immunotherapy, in the setting of advanced prostate cancer (PCa), may alter the lethal condition of advanced PCa into a chronic disease with significantly longer overall survival (OS), says an expert.